堪比商战大片!“减肥药新贵”遭巨头争抢,最新进展来了

中国基金报
Nov 08

【导读】辉瑞与Metsera达成合并协议修正案,修订后交易对Metsera估值高达每股86.25美元中国基金报记者晨曦辉瑞与诺和诺德对Metsera的争夺战,最新进展来了!当地时间11月7日,Metsera宣布,其已与辉瑞签订了修订后的合并协议。根据该协议,辉瑞将以每股最高86.25美元的价格收购Metsera,其中包括每股65.60美元的现金和或有价值权(CVR),持有人有权额外支付每股高达...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10